Literature DB >> 6132559

A comparison of patients who refuse and consent to neuroleptic treatment.

S R Marder, A Mebane, C P Chien, W J Winslade, E Swann, T Van Putten.   

Abstract

A recently enacted regulation in California requires that voluntary mental patients give signed informed consent for treatment with antipsychotic drugs. To evaluate the law's effects on schizophrenic patients, the authors compared 15 patients who refused to give consent with a matched group of 15 who gave consent. Refusers had significantly higher scores on the Brief Psychiatric Rating Scale for conceptual disorganization, emotional withdrawal, and unusual thought content. They were also more hostile, uncooperative, and mistrustful of the treatment team and more likely to believe they were not ill. The authors raise questions regarding the most appropriate consent process for schizophrenic patients.

Entities:  

Keywords:  Empirical Approach; Mental Health Therapies; Professional Patient Relationship

Mesh:

Substances:

Year:  1983        PMID: 6132559     DOI: 10.1176/ajp.140.4.470

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  9 in total

1.  One year outcome in first episode schizophrenia. Predictors of relapse.

Authors:  Alp Uçok; Aslihan Polat; Sibel Cakir; Aysun Genç
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-07-18       Impact factor: 5.270

2.  Social interaction and drug attitude effectiveness in patients with schizophrenia.

Authors:  Jui-Kang Tsai; Wen-Kuo Lin; For-Wey Lung
Journal:  Psychiatr Q       Date:  2011-12

3.  Psychometric properties of the Taiwanese version of the Illness Concept Scale: relation of health beliefs to psychopathology and medication compliance.

Authors:  Yu-Chen Kao; Yia-Ping Liu; Ming-Kuen Chou; Tsung-Hsing Cheng
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-04       Impact factor: 4.328

4.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Authors:  Martijn J Kikkert; Aart H Schene; Maarten W J Koeter; Debbie Robson; Anja Born; Hedda Helm; Michela Nose; Claudia Goss; Graham Thornicroft; Richard J Gray
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

5.  Compliance therapy in psychotic patients: randomised controlled trial.

Authors:  R Kemp; P Hayward; G Applewhaite; B Everitt; A David
Journal:  BMJ       Date:  1996-02-10

Review 6.  Patient compliance with drug therapy in schizophrenia. Economic and clinical issues.

Authors:  E Lindström; K Bingefors
Journal:  Pharmacoeconomics       Date:  2000-08       Impact factor: 4.981

7.  Demographic factors associated with extreme non-compliance in schizophrenia.

Authors:  W Sellwood; N Tarrier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1994-07       Impact factor: 4.328

8.  Adherence to medication for the treatment of psychosis: rates and risk factors in an Ethiopian population.

Authors:  Menna Alene; Michael D Wiese; Mulugeta T Angamo; Beata V Bajorek; Elias A Yesuf; Nasir Tajure Wabe
Journal:  BMC Clin Pharmacol       Date:  2012-06-18

9.  Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia.

Authors:  Hong Liu-Seifert; David H Adams; Haya Ascher-Svanum; Douglas E Faries; Bruce J Kinon
Journal:  Patient Prefer Adherence       Date:  2007-12-20       Impact factor: 2.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.